Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force and Nicholas King, Associate Professor in the Biomedical Ethics Unit, and Dick Menzies, Professor at the Department of Epidemiology, Biostatistics and Occupational Health, are among the experts quoted by the Montreal Gazette.
Dr. Nicholas King, Associate Professor in the Biomedical Ethics Unit, is among the experts quoted by CBC. Department of Epidemiology, Biostatistics and Occupational Health alumna Mabel Carabali is also quoted in this piece.
Dr. Nicholas King, Associate Professor in the Biomedical Ethics Unit, is among the experts quoted by Radio-Canada.
"Toutefois, pour Nicholas King, professeur d’éthique biomédicale à l’Université McGill, la question des risques que nous sommes prêts à assumer en vivant avec le virus, y compris une part de décès, est légitime et doit être posée. Cependant, établir un nombre de morts acceptable n’est pas la manière dont les sociétés et les gouvernements procèdent habituellement."
Dr. Nicholas King, Associate Professor in the Biomedical Ethics Unit, is among the experts quoted by CBC.
Dr. Nicholas King, Associate Professor in the Biomedical Ethics Unit, is among the experts quoted by Global News.
"…Nicholas King, a professor in the bioethics and epidemiology department at McGill University, said inequalities start to present themselves when travel is determined by the type of vaccine a person received."
Artificial intelligence (AI) is transforming our world in powerful ways, from improving medical care and changing the retail landscape to enabling convenient features on our smartphones. But as AI increasingly underpins our daily lives, important questions about its application – and potential misuse – will continue to arise.
The ongoing coronavirus crisis is exposing health inequities that have long existed in Canada. As well, Canadian charities and agencies are busy trying to meet the increased need brought on by the pandemic.
Prescriptions for dangerous alternatives to OxyContin are soaring, showing that a crackdown on the popular painkiller has failed to curb Canada’s opioid crisis.